WESTROCK COFFEE CO (WEST)

US96145W1036 - Common Stock

6.59  +0.24 (+3.78%)

After market: 6.59 0 (0%)

Fundamental Rating

1

Taking everything into account, WEST scores 1 out of 10 in our fundamental rating. WEST was compared to 90 industry peers in the Food Products industry. WEST may be in some trouble as it scores bad on both profitability and health. WEST has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

WEST had negative earnings in the past year.
In the past year WEST has reported a negative cash flow from operations.

1.2 Ratios

The Return On Assets of WEST (-4.07%) is worse than 76.19% of its industry peers.
The Return On Equity of WEST (-10.18%) is worse than 75.00% of its industry peers.
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

WEST's Gross Margin of 16.27% is on the low side compared to the rest of the industry. WEST is outperformed by 64.29% of its industry peers.
WEST does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

WEST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WEST has more shares outstanding
Compared to 1 year ago, WEST has a worse debt to assets ratio.

2.2 Solvency

WEST has an Altman-Z score of 1.29. This is a bad value and indicates that WEST is not financially healthy and even has some risk of bankruptcy.
WEST has a Altman-Z score of 1.29. This is in the lower half of the industry: WEST underperforms 73.81% of its industry peers.
WEST has a Debt/Equity ratio of 0.89. This is a neutral value indicating WEST is somewhat dependend on debt financing.
WEST has a Debt to Equity ratio of 0.89. This is in the lower half of the industry: WEST underperforms 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACCN/A
WACC8.87%

2.3 Liquidity

WEST has a Current Ratio of 1.31. This is a normal value and indicates that WEST is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of WEST (1.31) is worse than 60.71% of its industry peers.
WEST has a Quick Ratio of 1.31. This is a bad value and indicates that WEST is not financially healthy enough and could expect problems in meeting its short term obligations.
WEST's Quick ratio of 0.68 is on the low side compared to the rest of the industry. WEST is outperformed by 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.68

3

3. Growth

3.1 Past

The earnings per share for WEST have decreased strongly by -22.86% in the last year.
The Revenue has decreased by -0.36% in the past year.
EPS 1Y (TTM)-22.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.67%
Revenue 1Y (TTM)-0.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.57%

3.2 Future

Based on estimates for the next years, WEST will show a very strong growth in Earnings Per Share. The EPS will grow by 29.40% on average per year.
Based on estimates for the next years, WEST will show a quite strong growth in Revenue. The Revenue will grow by 10.28% on average per year.
EPS Next Y-55.43%
EPS Next 2Y29.65%
EPS Next 3Y29.4%
EPS Next 5YN/A
Revenue Next Year-3.15%
Revenue Next 2Y7.59%
Revenue Next 3Y10.28%
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

WEST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WEST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WEST is valued a bit more expensive than the industry average as 64.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 35.8

4.3 Compensation for Growth

A more expensive valuation may be justified as WEST's earnings are expected to grow with 29.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.65%
EPS Next 3Y29.4%

0

5. Dividend

5.1 Amount

No dividends for WEST!.
Industry RankSector Rank
Dividend Yield N/A

WESTROCK COFFEE CO

NASDAQ:WEST (1/3/2025, 8:10:18 PM)

After market: 6.59 0 (0%)

6.59

+0.24 (+3.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-13 2025-02-13/amc
Inst Owners31.34%
Inst Owner Change25.05%
Ins Owners5.06%
Ins Owner Change-0.71%
Market Cap620.71M
Analysts83.64
Price Target11.48 (74.2%)
Short Float %15.87%
Short Ratio16.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3070.57%
Min EPS beat(2)-6671.48%
Max EPS beat(2)530.34%
EPS beat(4)1
Avg EPS beat(4)-2146.95%
Min EPS beat(4)-6671.48%
Max EPS beat(4)530.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.65%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-6.76%
Revenue beat(4)0
Avg Revenue beat(4)-7.83%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-6.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.32%
PT rev (3m)-11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-250.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-25.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 1.6
P/tB 4.17
EV/EBITDA 35.8
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-2.43
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS11.36
BVpS4.12
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.27%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 15.65
Cap/Depr 619.86%
Cap/Sales 15.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.68
Altman-Z 1.29
F-Score2
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)327.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.67%
EPS Next Y-55.43%
EPS Next 2Y29.65%
EPS Next 3Y29.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.36%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.57%
Revenue Next Year-3.15%
Revenue Next 2Y7.59%
Revenue Next 3Y10.28%
Revenue Next 5YN/A
EBIT growth 1Y-133.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1143.29%
EBIT Next 3Y219.97%
EBIT Next 5YN/A
FCF growth 1Y-90.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.13%
OCF growth 3YN/A
OCF growth 5YN/A